Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DS0P | ISIN: US8342033094 | Ticker-Symbol: 6XC
Tradegate
09.05.24
19:10 Uhr
43,420 Euro
+1,640
+3,93 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SOLENO THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SOLENO THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
41,06042,50010.05.
41,14042,42010.05.

Aktuelle News zur SOLENO THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSoleno Therapeutics GAAP EPS of -$0.59 misses by $0.222
DoSOLENO THERAPEUTICS INC - 10-Q, Quarterly Report2
DiSOLENO THERAPEUTICS INC - 8-K, Current Report1
03.05.Soleno Therapeutics announces pricing of $138M public offering1
03.05.Soleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hours-
03.05.Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock1
02.05.Soleno Therapeutics announces proposed common stock offering1
02.05.Soleno Therapeutics Announces Proposed Public Offering of Common Stock1
29.04.Why Soleno Therapeutics Stock Is Skyrocketing Today7
29.04.Soleno Therapeutics receives breakthrough therapy designation from FDA for PWS treatment8
22.04.SOLENO THERAPEUTICS INC - 8-K, Current Report3
19.04.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)50REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
► Artikel lesen
08.03.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)62REDWOOD CITY, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
► Artikel lesen
07.03.SOLENO THERAPEUTICS INC - 8-K, Current Report3
07.03.SOLENO THERAPEUTICS INC - 10-K, Annual Report-
06.03.Soleno Therapeutics GAAP EPS of -$0.33 misses by $0.072
06.03.Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results78REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
► Artikel lesen
22.02.Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference4
05.02.Piper Sandler sets $93 target for Soleno Therapeutics7
31.01.SOLENO THERAPEUTICS INC - S-8, Securities to be offered to employees in employee benefit plans3
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1